n.a. (SGNL)

8.76
0.18 2.01
NASDAQ
Prev Close 8.94
Open 8.95
Day Low/High 8.59 / 8.98
52 Wk Low/High 1.80 / 18.00
Volume 44.38K
Exchange NASDAQ
Div & Yield N.A. (N.A)

Latest News

MiRagen Therapeutics And Signal Genetics Sign Merger Agreement

MiRagen Therapeutics And Signal Genetics Sign Merger Agreement

Signal Genetics, Inc. (Nasdaq: SGNL) ("Signal") and Miragen Therapeutics, Inc.

These 5 Stocks Under $10 Are Set to Soar

These 5 Stocks Under $10 Are Set to Soar

Here's a technical look at how to trade five stocks trading for less than $10 a share.

Signal Genetics Highlights Recent Achievements And Reports First Quarter 2016 Financial Results

Signal Genetics Highlights Recent Achievements And Reports First Quarter 2016 Financial Results

Record Volume and Net Revenue from MyPRS® Sold to Clinical Customers

Signal Genetics Highlights Recent Achievements And Reports Fourth Quarter And Full-Year 2015 Financial Results

Signal Genetics Highlights Recent Achievements And Reports Fourth Quarter And Full-Year 2015 Financial Results

Record Volume of MyPRS® Clinical Tests Sold for Q4 and Full Year

Signal Genetics To Host 2015 Annual Corporate Update Call

Signal Genetics To Host 2015 Annual Corporate Update Call

Call to Provide Overview of 2015 Results

Signal Genetics And MD Anderson Cancer Center Enter Into Sponsored Research Agreement

Signal Genetics And MD Anderson Cancer Center Enter Into Sponsored Research Agreement

200 Patient Study Designed to Advance Signal Genetics' MyPRS® Assay

Signal Genetics Highlights Recent Achievements And Reports Third Quarter 2015 Financial Results

Signal Genetics Highlights Recent Achievements And Reports Third Quarter 2015 Financial Results

Record Volume of MyPRS(R) Tests Sold, Increasing 82% Year-Over-Year, to Customers Outside of the University of Arkansas for Medical Sciences (UAMS)

Signal Genetics' MyPRS(R) Highlighted In The Journal Leukemia

Signal Genetics' MyPRS(R) Highlighted In The Journal Leukemia

Peer-Reviewed Publication Demonstrates Clinical Utility of MyPRS(R)

Signal Genetics (SGNL) Stock Jumps on New Master Service Agreement

Signal Genetics (SGNL) Stock Jumps on New Master Service Agreement

Signal Genetics (SGNL) shares are gaining after signing a new master service agreement with a major biopharmaceutical company.

5 Stocks Ready for Breakouts

5 Stocks Ready for Breakouts

These stocks look ready to break out and trade higher from current levels.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CCK, DIT, DOC, FIVE, REXR Downgrades: CTL, DCUB, JOUT, NEWP, PANW, RMBS, STLD, ZINC Initiations: CCS, FELP, PSG, SGNL, TMST, VRTV Read on to get TheStreet Quant Ratings' detailed report:

Signal Genetics (SGNL) Stock Gains on New Master Service Agreement

Signal Genetics (SGNL) Stock Gains on New Master Service Agreement

Signal Genetics (SGNL) shares gain after the company announced a new master service agreement with a pharmaceutical company.